CIX vs EXAS · P/E 18, rev $43.6M vs rev $2.76B
CompX International Inc (CIX) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
CompX International Inc (CIX) is a security & protection services company listed on US.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported CIX revenue for 2026-06-30 was $43.6M. Net income was $7.3M. Revenue was up 7.5% from 2026-03-31 to 2026-06-30. CIX currently screens at market cap $318.2M and trailing P/E 17.7.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
CIX currently screens at market cap $318.2M and trailing P/E 17.7. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the CIX and EXAS stock pages for the full models.
Not investment advice.